NEW YORK, NY / ACCESSWIRE / March 18, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
Qudian Inc. (NYSE:QD)
Investors Affected: December 13, 2018 - January 15, 2020
A class action has commenced on behalf of certain shareholders in Qudian Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) regulatory developments in China threatened to negatively impact Qudian's fiscal full-year 2019 ("FY19") financial results; (ii) Qudian's business was unprepared to mitigate the risks associated with these regulatory changes; (iii) as a result, Qudian's loan portfolio was plagued by growing delinquency rates; (iv) all of the foregoing made Qudian's repeated assertions concerning its FY19 financial guidance unrealistic; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/qudian-inc-loss-submission-form/?id=5720&from=1
Align Technology, Inc. (NASDAQ:ALGN)
Investors Affected: April 24, 2019 - July 24, 2019
A class action has commenced on behalf of certain shareholders in Align Technology, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) Align was then experiencing a significant decline in demand for its products in the important Chinese market; (b) Chinese consumer sentiment towards the Company was deteriorating; and (c) as a result of the foregoing, Defendants' positive statements about Align and its businesses were lacking in a reasonable basis.
Shareholders may find more information at https://securitiesclasslaw.com/securities/align-technology-inc-loss-submission-form/?id=5720&from=1
Inovio Pharmaceuticals, Inc. (NASDAQ:INO)
Investors Affected: February 14, 2020 - March 9, 2020
A class action has commenced on behalf of certain shareholders in Inovio Pharmaceuticals, Inc. According to a filed complaint, throughout the class period, defendants made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.
Shareholders may find more information at https://securitiesclasslaw.com/securities/inovio-pharmaceuticals-inc-loss-submission-form/?id=5720&from=1
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com:
https://www.accesswire.com/581361/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-QD-ALGN-and-INO
